Director, Professor Villis Marshall AC
An internationally recognized consultant specialist, educator and researcher in urology. Professor Marshall is currently appointed as General Manager at the Royal Adelaide Hospital, Clinical Director of Surgical and Specialities Service, Royal Adelaide Hospital and Strategic Clinical Director of Acute Services, Central Northern Adelaide Health Service. He Chairs the Executive Committee of the Australian Prostate Cancer Collaboration.
Professor Marshall has been awarded Companion of the Order of Australia (AC) for service to medicine in urology and kidney disease research. He was also awarded the Bailiff Grand Cross of the Order of St John of Jerusalem, the Order's highest award. Professor Marshall currently holds 14 memberships of learned societies, has published over 300 articles and has received over 50 research grants.
Executive Manager, Dr Vanessa Glennon
Dr Glennon combines scientific achievement with extensive communications expertise. She has a PhD in Biological Sciences from the University of Adelaide in South Australia and over ten years international experience in broadcast media.
During her scientific and professional careers, she has held a range of technical and creative positions demonstrating skills and expertise in project development and planning, project management, analysis, publication writing, teaching and public presentation.
Professor Gary Wittert
Currently Mortlock Professor of Medicine, and Head of the Discipline of Medicine at the University of Adelaide, Senior Consultant Endocrinologist at the Royal Adelaide Hospital, and a member of the Hanson Research Institute. Professor Wittert is a past president of the Australasian Society for the Study of Obesity, and is currently vice president of the Asia Oceania Association of the Study of Obesity.
Prof Wittert is the lead investigator on the Florey Adelaide Male Aging Study (FAMAS), and is also an investigator in the North West Adelaide Obesity and Lifestyle and Environment (NOBLE) Study, and the Men in Australia, Telephone Survey (MATeS). He is also the principle investigator of a number of clinical trials of novel drugs to treat obesity and type 2 diabetes mellitus. Professor Wittert has authored over one hundred peer-reviewed papers and book chapters, and is a founding Editor in Chief of the "Journal of Obesity Research and Clinical Practice".
Professor Wayne Tilley
Chair of the Dame Roma Mitchell Cancer Research Laboratories and Head of the Cancer Research Centre at the Hanson Institute. Through his National Health and Medical Research Council (NHMRC) CJ Martin Fellowship at University of Texas Southwestern in Dallas, Texas, Professor Tilley was one of the first to clone the human androgen receptor (AR), which is the key cellular mediator of the effects of testicular androgens. Since then, Professor Tilley's laboratory has made a major contribution to understanding the molecular mechanisms of resistance to conventional hormonal (androgen ablation) therapies used in the treatment of prostate cancer.
He was a Director of the Australian Society for Medical Research (1984-1987; 1991-1993), being President in 1993. Professor Tilley is a Board member of Andrology Australia and currently chair of the Research Advisory Committee of the National Breast Cancer Foundation. Professor Tilley has published more than 100 publications, and his research has been presented at numerous international meetings.
Professor Deborah Turnbull
School of Psychology, University of Adelaide. Professor Turnbull's research background is in Public Health and Applied Psychology. Her research interests are in health service development and evaluation, including that for maternity care, screening, primary care mental health and disease management.
Professor Turnbull holds numerous research grants and serves on a range of state and national committees including the Australian Primary Health Care Research Institute and the NSW Cancer Institute. With respect to the field of men's health, Professor Turnbull's major research interest concerns mental health.
Dr Lisa Butler
Senior Research Fellow, Dame Roma Mitchell Cancer Research Laboratories, Hanson Institute, University of Adelaide. During postdoctoral training at Memorial Sloan-Kettering Cancer Centre in New York, Dr Butler was the first to demonstrate that a new class of histone deacetylase inhibitors had potent biological activity against prostate tumours, prompting clinical trials in the USA. Since this time the field of histone deacetylase inhibitors has expanded considerably.
Currently, Dr Butler heads a molecular therapeutics research group which focuses on novel combinatorial approaches to target androgen signalling in prostate and breast cancer.